Lupin receives USFDA approval for Sevelamer Hydrochloride tablets

Mumbai/UNI: Pharma major Lupin on Thursday said that it has received approval for its Sevelamer Hydrochloride Tablets, 400 mg and 800 mg from the United States Food and Drug Administration (USFDA) to market a generic equivalent of Renagel Tablets, 400 mg, and 800 mg of Genzyme Corporation.

Zydus Cadila receives final approval from USFDA for Deferasirox Tablets

Mumbai/UNI: Pharma major, Zydus Cadila on Tuesday said it has received final approval from the USFDA to market Deferasirox Tablets in the strengths of 90 mg, 180 mg and 360 mg.

Strides Pharma receives USFDA approval for Triamcinolone Acetonide Ointment USP, 0.05%

Bengaluru/IBNS: Strides Pharma Science Limited (Strides) announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Triamcinolone Acetonide Ointment USP, 0.05% from the United States Food & Drug Administration (USFDA).

USFDA clears manufacturing plants of India's leading drug companies in 10 days

Washington/Mumbai/IBNS: The US Food and Drug Administration (USFDA) has cleared the manufacturing plants of India's leading drug companies in 10 days, media reports said.